Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5WJJ

Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[1,2-b]pyridazine-based p38 MAP Kinase Inhibitors

Summary for 5WJJ
Entry DOI10.2210/pdb5wjj/pdb
DescriptorMitogen-activated protein kinase 14, N-{4-[2-(4-fluoro-3-methylphenyl)imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl}-2-methyl-1-oxo-1lambda~5~-pyridine-4-carboxamide (3 entities in total)
Functional Keywordstransferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (Human)
Cellular locationCytoplasm : Q16539
Total number of polymer chains1
Total formula weight42168.98
Authors
Snell, G.P.,Okada, K.,Bragstad, K.,Sang, B.-C. (deposition date: 2017-07-23, release date: 2018-01-17, Last modification date: 2024-03-13)
Primary citationKaieda, A.,Takahashi, M.,Takai, T.,Goto, M.,Miyazaki, T.,Hori, Y.,Unno, S.,Kawamoto, T.,Tanaka, T.,Itono, S.,Takagi, T.,Hamada, T.,Shirasaki, M.,Okada, K.,Snell, G.,Bragstad, K.,Sang, B.C.,Uchikawa, O.,Miwatashi, S.
Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors.
Bioorg. Med. Chem., 26:647-660, 2018
Cited by
PubMed: 29291937
DOI: 10.1016/j.bmc.2017.12.031
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.6 Å)
Structure validation

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon